United States · FDA National Drug Code directory

levothyroxine sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1478_5dd258ee-53fd-4e60-b3c9-b3cfacd622bf
Product NDC
71335-1478
Form
TABLET
Composition / generic term
levothyroxine sodium
Labeler
Bryant Ranch Prepack
Marketing category
NDA
Marketing start / end (source format)
20190507
Source listing expiry
20261231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — 100 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1000 TABLET in 1 BOTTLE (71335-1478-0) · 71335-1478-0
  • 100 TABLET in 1 BOTTLE (71335-1478-1) · 71335-1478-1
  • 30 TABLET in 1 BOTTLE (71335-1478-2) · 71335-1478-2
  • 60 TABLET in 1 BOTTLE (71335-1478-3) · 71335-1478-3
  • 7 TABLET in 1 BOTTLE (71335-1478-4) · 71335-1478-4
  • 14 TABLET in 1 BOTTLE (71335-1478-5) · 71335-1478-5
  • 90 TABLET in 1 BOTTLE (71335-1478-6) · 71335-1478-6
  • 28 TABLET in 1 BOTTLE (71335-1478-7) · 71335-1478-7
  • 56 TABLET in 1 BOTTLE (71335-1478-8) · 71335-1478-8
  • 180 TABLET in 1 BOTTLE (71335-1478-9) · 71335-1478-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →